Y Mabs Therapeutics Inc Revenue per Employee (YMAB), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Y mabs Therapeutics inc   (NASDAQ: YMAB)
 

Y Mabs Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Y Mabs Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 847,210, but the productivity of Y Mabs Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 111 other companies have achieved higher revenue per employee. While Y Mabs Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 872 to 934. Y Mabs Therapeutics Inc has 100 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

YMAB Revenue per Employee (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Revenue Change -17.26 % 4.88 % 13.4 % -9.74 % 9.86 %
Sales per Employee (TTM) $ 847,210 886,560 876,840 845,530 865,460
YMAB's Total Ranking # 934 # 872 # 518 # 577 # 550
Seq. Revenue Change -9.76 % -21.1 % 43.51 % -19.02 % 14.38 %

YMAB Company Profile >> Back to YMAB Efficiency Comparisons >> Compare YMAB Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 60
Healthcare Sector # 112
Overall Market # 934

Revenue per Employee Statistics
High Average Low
$ 929,030 $ 703,125 $ 348,970
(Sep 30 2023)   (Dec 31 2021)



Financial Statements
Y Mabs Therapeutics Inc 's Revenue MRQ $ 19 Millions Visit YMAB's Income Statement
Y Mabs Therapeutics Inc 's Revenues TTM $ 85 Millions Visit YMAB's aggregate revenue growth
What are YMAB's Sales? Visit YMAB's Sales by Segment




Other Ratios
Y Mabs Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
YMAB's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for YMAB's Competitors
Revenue per Employee for YMAB's Suppliers
Revenue per Employee for YMAB's Customers

You may also want to know
YMAB's Sales Growth Rates YMAB's Pe Price to earnings ratio YMAB's Receivables Turnover Ratio YMAB's Stock Quote
YMAB's Net Income Growth Rates YMAB's Ps Price to Sales ratio YMAB's Sales per Employee YMAB's Asset Turnover Ratio
YMAB's Net Margin YMAB's Pb Price to Book ratio YMAB's Financial Strength Ratios YMAB's Dividend Payout Ratio
Date modified: 2026-08-29T17:41:26+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2025Number of Employees Jun 30 2025
Bristol myers Squibb Company  1,467,815.38 $ 47,704.000  Million 32,500 
Progyny Inc   1,450,285.05 $ 1,241.444  Million 856 
Kiniksa Pharmaceuticals International Plc  1,446,262.30 $ 529.332  Million 366 
Novavax inc   1,440,210.95 $ 1,078.718  Million 749 
Avadel Pharmaceuticals Plc  1,436,136.36 $ 221.165  Million 154 
Jazz Pharmaceuticals Plc  1,414,081.31 $ 4,086.695  Million 2,890 
Semler Scientific inc   1,386,387.10 $ 42.978  Million 31 
Biogen Inc   1,332,933.33 $ 9,997.000  Million 7,500 
Eton Pharmaceuticals Inc   1,330,977.27 $ 58.563  Million 44 
Puma Biotechnology Inc   1,329,955.31 $ 238.062  Million 179 
Scilex Holding Company  1,301,058.82 $ 44.236  Million 34 
Biocryst Pharmaceuticals Inc   1,281,622.99 $ 557.506  Million 435 
Acadia Pharmaceuticals Inc   1,276,799.50 $ 1,018.886  Million 798 
Lantheus Holdings Inc   1,274,419.11 $ 1,520.382  Million 1,193 
Agenus Inc  1,255,629.63 $ 101.706  Million 81 
Neurocrine Biosciences Inc   1,254,950.00 $ 2,509.900  Million 2,000 
Vaxart Inc   1,241,907.69 $ 80.724  Million 65 
Xenetic Biosciences Inc   1,223,110.50 $ 2.446  Million 2 
Krystal Biotech Inc   1,217,647.46 $ 359.206  Million 295 
Nektar Therapeutics  1,189,428.57 $ 74.934  Million 63 
Monte Rosa Therapeutics Inc   1,186,573.33 $ 177.986  Million 150 
Anaptysbio Inc   1,184,269.23 $ 123.164  Million 104 
Stoke Therapeutics Inc   1,175,847.06 $ 199.894  Million 170 
Heron Therapeutics Inc   1,161,671.88 $ 148.694  Million 128 
Mirum Pharmaceuticals Inc   1,153,658.60 $ 429.161  Million 372 
Dynavax Technologies Corporation  1,150,061.82 $ 316.267  Million 275 
Tg Therapeutics Inc   1,138,015.04 $ 454.068  Million 399 
Amicus Therapeutics inc   1,115,393.35 $ 569.966  Million 511 
Arcturus Therapeutics Holdings Inc   1,100,198.20 $ 122.122  Million 111 
Marker Therapeutics inc   1,077,614.20 $ 5.388  Million 5 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.